Phase I study of weekly intraperitoneal paclitaxel combined with oxaliplatin plus S-1 for advanced gastric cancer with peritoneal metastasis.
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2011
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary)
- Indications Cancer metastases; Gastric cancer
- Focus Adverse reactions
- 07 Feb 2011 New trial record